Ian Rowe
@IanARowe
Associate Professor & Hepatologist at University of Leeds. Interested in liver disease and treatment of cirrhosis and HCC. Views my own.
ID:962187001
http://www.rowe-liver.com 21-11-2012 10:48:44
2,1K Tweets
2,2K Followers
1,3K Following
UK Hepatology #livertwitter - which set of clinical practice guidelines most shape your management of patients with all aspects of compensated cirrhosis
BSG Frontline Gastro
EASL Education AASLD
Please share and comment too!
What do patients want MASLD care to look like? Call for participants with or at risk of #MASLD to join our qualitative study. Spread the word! Liverpool Centre for Cardiovascular Science Liverpool University Hospitals NHS FT University of Liverpool Dr Helen Jarvis Ian Rowe Ryan Buchanan Katie Williams Daniel Cuthbertson British Liver Trust Academy of Medical Sciences
Can't wait to get started on this important trial!
Leeds Teaching Hospitals Leeds Research & Innovation
Looking forward to contributing to this event!
Talking about what being a clinical academic is really like
Leeds Research & Innovation UniLeedsMed&Health 💙
While this study provides some credence to the idea that testing might impact behaviour there is no control group
A causal interpretation is not appropriate
Whether, and to what extent, testing alone impacts risk factors for SLD and ArLD is still unclear
#livertwitter
⭐️ Everything you need to know about #Lactulose in Cirrhosis‼️
✅-out this 🔥 Review 📑 in Hepatology Communications
#LiverTwitter #GITwitter
journals.lww.com/hepcomm/fullte…
🧵 below!
Sometimes I think I'd like to be a perpetual research fellow when projects like this come along
Great opportunity to work with a great team!
BASL education feed BSG Trainees #livertwitter
Huge, important study in Hepatology Communications
1⃣Prevalence of Alcohol-related liver disease, MASLD, and MetALD
2⃣Severity of liver disease by subtype for 🇺🇸
3⃣Impact of social determinants of health
journals.lww.com/hepcomm/fullte…
Comprehensive, robust, high impact work Pedro Ochoa-Allemant
Angela Eddy Ian Rowe Cancer Research UK Policy have been key supporters of NCD prevention policy, including alcohol for some years now. This report is an example. twitter.com/InstAlcStud/st…
Credit where it's due!
We are particularly interested in hearing from clinicians in #PrimaryCare - GPs, practice nurses PACT - Primary care Academic CollaboraTive
Share your views on care pathways and assessment of #liver disease risk in persons with multiple long-term conditions
Register your interest now! forms.gle/74qVzXiBf22VC9…
A huge privilege to be able to visit @PennGIHep and talk about all aspects of liver disease and transplant with faculty and fellows
So much to learn and to do to understand outcomes in #MASLD and other live diseases
Thank you Marina Serper, MD, MS for inviting me!
#livertwitter
⭐️⭐️ Hepatology Communications Editorial Board is here at AASLD #TLM23 ‼️⭐️⭐️
💥We remain committed to the Respectful, Efficient (🕰️), and Constructive review of your research manuscripts! 📑
#LiverTwitter #OpenAccess
journals.lww.com/hepcomm/pages/…
Sugar-associated liver disease
I am so excited to see this paper online Hepatology Communications from Huneault and Vos.
Everything from pathophysiology, epidemiology, to effect of sugar taxes and restriction diets #liverwitter #TLM23
Open access: journals.lww.com/hepcomm/fullte…